These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 17724659

  • 1. Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF-SIMS.
    Chesko J, Kazzaz J, Ugozzoli M, Singh M, O'Hagan DT, Madden C, Perkins M, Patel N.
    J Pharm Sci; 2008 Apr; 97(4):1443-53. PubMed ID: 17724659
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.
    Singh M, Kazzaz J, Chesko J, Soenawan E, Ugozzoli M, Giuliani M, Pizza M, Rappouli R, O'Hagan DT.
    J Pharm Sci; 2004 Feb; 93(2):273-82. PubMed ID: 14705185
    [Abstract] [Full Text] [Related]

  • 4. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
    Kazzaz J, Singh M, Ugozzoli M, Chesko J, Soenawan E, O'Hagan DT.
    J Control Release; 2006 Feb 21; 110(3):566-73. PubMed ID: 16360956
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not.
    Singh M, Chesko J, Kazzaz J, Ugozzoli M, Kan E, Srivastava I, O'Hagan DT.
    Pharm Res; 2004 Dec 21; 21(12):2148-52. PubMed ID: 15648244
    [Abstract] [Full Text] [Related]

  • 7. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.
    Jain S, O'Hagan DT, Singh M.
    Expert Rev Vaccines; 2011 Dec 21; 10(12):1731-42. PubMed ID: 22085176
    [Abstract] [Full Text] [Related]

  • 8. A two-stage strategy for sterilization of poly(lactide-co-glycolide) particles by γ-irradiation does not impair their potency for vaccine delivery.
    Jain S, Malyala P, Pallaoro M, Giuliani M, Petersen H, O'Hagan DT, Singh M.
    J Pharm Sci; 2011 Feb 21; 100(2):646-54. PubMed ID: 20665902
    [Abstract] [Full Text] [Related]

  • 9. Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.
    Singh M, Kazzaz J, Ugozzoli M, Malyala P, Chesko J, O'Hagan DT.
    Curr Drug Deliv; 2006 Jan 21; 3(1):115-20. PubMed ID: 16472100
    [Abstract] [Full Text] [Related]

  • 10. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A, Lavelle EC, Hartshorne M, Davis SS.
    Vaccine; 1999 Jul 16; 17(22):2927-38. PubMed ID: 10438065
    [Abstract] [Full Text] [Related]

  • 11. Surface characteristics of spray-dried microspheres consisting of PLGA and PVP: relating the influence of heat and humidity to the thermal characteristics of these polymers.
    Meeus J, Scurr DJ, Amssoms K, Davies MC, Roberts CJ, Van den Mooter G.
    Mol Pharm; 2013 Aug 05; 10(8):3213-24. PubMed ID: 23844639
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC, Yeh MK, Coombes AG, Davis SS.
    Vaccine; 1999 Feb 12; 17(6):512-29. PubMed ID: 10075157
    [Abstract] [Full Text] [Related]

  • 14. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
    Coombes AG, Tasker S, Lindblad M, Holmgren J, Hoste K, Toncheva V, Schacht E, Davies MC, Illum L, Davis SS.
    Biomaterials; 1997 Sep 12; 18(17):1153-61. PubMed ID: 9259512
    [Abstract] [Full Text] [Related]

  • 15. Adsorption of poly(ethylene glycol)-modified ribonuclease A to a poly(lactide-co-glycolide) surface.
    Daly SM, Przybycien TM, Tilton RD.
    Biotechnol Bioeng; 2005 Jun 30; 90(7):856-68. PubMed ID: 15841471
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of anionic nanoparticles and microparticles as vaccine delivery systems.
    Wendorf J, Chesko J, Kazzaz J, Ugozzoli M, Vajdy M, O'Hagan D, Singh M.
    Hum Vaccin; 2008 Jun 30; 4(1):44-9. PubMed ID: 18438105
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.